IOL Chemicals and Pharmaceuticals profit decreases 9.57% in (Q3) FY 2020-21

Source

Team Infinities:

IOL Chemicals and Pharmaceuticals Limited NSE Symbol:IOLCP, BSE Security Code:524164 has declared its 3rd(third) quarter audited standalone financial report from the month of October, 2020 to the month of December, 2020; for the fiscal year 2020-21.

Revenue Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
520.82 537.96 515.21 1524.69 1463.68
Calculated Revenue of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
17.14 3.19%(Revenue Decrease) 5.61 1.09%(Revenue Increase) 61.01 4.17%(Revenue Increase)

Revenue: IOL Chemicals and Pharmaceuticals Limited's financial report shows that the company's revenue decreased by 3.19% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for revenue decrease of Rs.17.14 crores, as the company posted revenue of Rs.520.82 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported revenue of Rs.537.96 crores.
The result also shows that the company's revenue increased by 1.09% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for revenue increase of Rs.5.61 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted revenue of Rs.515.21 crores.
The company also reported that its revenue increased by 4.17% in 9 months end(April, 2020 - December, 2020) for revenue increase of Rs.61.01 crores, since the company reported revenue of Rs.1524.69 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted revenue of Rs.1463.68 crores.

Gross Margin(%) Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
42.88 37.91 47.24 41.62 46.92
Calculated Gross Margin(%) of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
4.97 13.12%(GM Increase) 4.36 9.23%(GM Decrease) 5.30 11.30%(GM Decrease)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 13.12% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for 4.97% GM increase, as the company reported 42.88% GM; in compare to previous quarter(July, 2020 - September, 2020) when the company reported 37.91% GM.
The result also indicates, the company's GM decreased by 9.23% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for 4.36% GM decrease; in compare to corresponding quarter(October, 2019 - December, 2019) when the company reported 47.24% GM.
The company also reported that its GM decreased by 11.30% in 9 months end(April, 2020 - December, 2020) for 5.30% GM decrease, since the company reported 41.62% GM; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company reported 46.92% GM.

EBITDA Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
165.06 175.78 163.46 498.76 447.70
Calculated EBITDA of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
10.72 6.10%(EBITDA Decrease) 1.60 0.98%(EBITDA Increase) 51.06 11.40%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 6.10% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EBITDA decrease of Rs.10.72 crores, as the company posted EBITDA of Rs.165.06 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EBITDA of Rs.175.78 crores.
The result also shows that the company's EBITDA increased by 0.98% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.1.60 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EBITDA of Rs.163.46 crores.
The company also reported that its EBITDA increased by 11.40% in 9 months end(April, 2020 - December, 2020) for EBITDA increase of Rs.51.06 crores, since the company reported EBITDA of Rs.498.76 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EBITDA of Rs.447.70 crores.

Profit and Loss Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
114.81(Profit ) 126.96(Profit ) 98.01(Profit ) 369.31(Profit ) 271.03(Profit )
Calculated Profit and Loss of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
12.15 9.57%(Profit Decrease) 16.80 17.14%(Profit Increase) 98.28 36.26%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 9.57% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for profit decrease of Rs.12.15 crores, as the company posted profit of Rs.114.81 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported profit of Rs.126.96 crores.
The result also shows that the company's profit increased by 17.14% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for profit increase of Rs.16.80 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted profit of Rs.98.01 crores.
The company also reported that its profit increased by 36.26% in 9 months end(April, 2020 - December, 2020) for profit increase of Rs.98.28 crores, since the company reported profit of Rs.369.31 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted profit of Rs.271.03 crores.

EPS Reported by IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
19.54 21.61 17.22 63.45 47.64
Calculated EPS of IOL Chemicals and Pharmaceuticals Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
2.07 9.58%(EPS Decrease) 2.32 13.47%(EPS Increase) 15.81 33.19%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 9.58% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EPS decrease of Rs.2.07, as the company posted EPS of Rs.19.54; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EPS of Rs.21.61.
The result also shows that the company's EPS increased by 13.47% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EPS increase of Rs.2.32; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EPS of Rs.17.22.
The company also reported that its EPS increased by 33.19% in 9 months end(April, 2020 - December, 2020) for EPS increase of Rs.15.81, since the company reported EPS of Rs.63.45; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EPS of Rs.47.64.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.